Delivery Order SPE2DB22D6029-SPE2DB25FLVYQ
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,316.47 to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials on July 23, 2025, with a ceiling value of $2,186.12. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction to support federal medical procurement needs. The contract is scheduled for completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials totaling $1,482.82. This competitively awarded, non-set-aside contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The delivery order represents a firm fixed price transaction with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Hydralazine 20 mg/mL vials under a firm fixed-price arrangement. The contract, with a ceiling value of $1,604.30 and a completion date of September 8, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp has been awarded a delivery order contract valued at $1,352.78 for the supply of Hydromorphone 1 mg/mL by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery is scheduled for completion by...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $158,944.60 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The work will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,250.47 to AmerisourceBergen Drug Corp on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The vendor, headquartered in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,546.54 by the Defense Logistics Agency's Medical Supply Chain on June 18, 2025. This competitive, non-set-aside contract reflects a firm fixed price arrangement with an ultimate completion date of June 20, 2025. The delivery order represents a direct procurement of pharmaceutical products and medical supplies to support federal healthcare...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $109,124.26 to AmerisourceBergen Drug Corp on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The contract is performed at AmerisourceBergen's corporate office location in...